Please assess the completion status of the following clinical trial:

Trial Title: A Single Supplement of a Standardised Bilberry Extract Modifies Glycaemic Response

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male subjects~* Aged \>40 and \<70~* Clinical diagnosis of Type 2 diabetes controlling their diabetes by diet alone~* All subjects must live in the Aberdeenshire area of Scotland~Exclusion Criteria:~* Medical exclusion criteria~* Clinical diagnosis of thromboembolic or coagulation disease~* Clinical diagnosis of unregulated thyroid disease~* Clinical diagnosis of kidney disease~* Clinical diagnosis of severe gastrointestinal disorders~* History of Alcohol or any other substance abuse

- Gender: MALE
- Minimum Age: 40 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Bilberry capsule first, then control cap (Type: EXPERIMENTAL): Volunteers will be given a single capsule of 0.47 grams of mirtoselect (a concentrated bilberry extract) followed by a 14 day washout period then a single control placebo capsule.~First Intervention (1 day), Washout (14 days), Second Intervention (1 day)
- Control capsule first, then bilberry cap (Type: EXPERIMENTAL): Volunteers will be given a single control placebo capsule followed by a 14 day washout period the a single capsule of 0.47 grams of mirtoselect (a concentrated bilberry extract)~First Intervention (1 day), Washout (14 days), Second Intervention (1 day)

Based on this trial design, predict the completion outcome and termination type (if applicable).